First locally acquired case of dengue in California detected in a Pasadena resident
On Oct. 30, 2023, the California Department of Public Health (CDPH) reported the first locally acquired case of…
-
-
SARS-CoV-2 infects coronary arteries, increases plaque inflammation
On Sept. 28, 2023, the National Institute of health announced SARS-CoV-2, the virus that causes COVID-19, can directly…
-
Researchers demonstrated heat-induced pyroelectricity in viruses
On Sept. 25, 2023, researchers at the University of California, Berkeley reported that engineered viruses also can generate…
-
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
-
Project NextGen awarded over $1.4 billion to develop future of COVID-19 vaccines and therapeutics
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
-
CDC reported two human infections with swine flu viruses
On Aug. 4, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported the first two U.S….
-
U.S. FDA approved Merck’s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…
-
Scientists developed breath test that rapidly detects COVID-19 virus
On Jul. 31, 2023, scientists at Washington University in St. Louis have developed a breath test that quickly…
-
Biotechnology | FDA | Vaccine
U.S. FDA approved Ervebo first U.S.-licensed vaccine for prevention of Ebola virus disease
On Jul. 28, 2023, the U.S. Food and Drug Administration (FDA) approved Merck’s Ervebo, a vaccine for the…
-
Biotechnology | COVID-19 | Disease | WHO
Middle East Respiratory Syndrome reported in United Arab Emirates
On Jul. 24, 2023, the United Arab Emirates (UAE), notified WHO of a case of Middle East Respiratory…
-
Report published in Nature detailed transmission of SARS-CoV-2 in free-ranging white-tailed deer in the U.S.
On Jul. 10, 2023, a report published in the journal Nature detailed frequent spillovers of SARS-CoV-2 from humans…
-
University of Illinois Urbana-Champaign team developed all-species coronavirus test
On Jul. 6, 2023, University of Illinois Urbana-Champaign researchers reported they can detect exposure to the SARS-CoV-2 virus…
-
Biotechnology | Diagnostics | Disease | FDA | Rare Disease | Therapeutics
U.S. FDA approved BioMarin’s ROCTAVIAN, the first and only gene therapy for adults with severe hemophilia A
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
-
Tanzania declared the end of its first documented outbreak of Marburg virus disease
On Jun. 2, 2023, the Ministry of Health of the United Republic of Tanzania declared the end of…
-
WHO announced simple, easy-to-say labels for SARS-CoV-2 Variants of Interest and Concern
On May 31, 2023, the World Health Organization announced it had assigned simple, easy to say and remember…
-
NIH study identified features of Long COVID neurological symptoms
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
-
World Health Organization reported enterovirus infections in France
On May 5, 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11…
-
Biotechnology | FDA | Therapeutics | Vaccine
U.S. FDA approved first Respiratory Syncytial Virus (RSV) vaccine
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
-
Elanco announced breakthrough treatment for deadly canine parvovirus
On May 2, 2023, Elanco Animal Health announced that the U.S. Department of Agriculture had provided a conditional…
-
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
-
Biotechnology | FDA | Therapeutics | Vaccine
U.S. FDA approved PREVNAR 20, Pfizer’s 20-valent pneumococcal conjugate vaccine for infants and children
On Apr. 27, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
-
Avian Influenza A (H5N1) reported in Cambodia
On Feb. 26, 2023, the Cambodia International Health Regulations (IHR) National Focal Point (NFP) reported one confirmed case…
-
FDA authorized first OTC at-home test to detect both influenza and COVID-19 viruses
On Feb. 24, 2023, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…
-
Researchers document third known case of HIV remission involving stem cell transplant
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
-
NIH scientists develop mouse model to study Mpox virulence
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
-
Equatorial Guinea confirmed first-ever Marburg virus disease outbreak
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Influenza | Vaccine
BD received FDA EUA for COVID-19, influenza A/B, RSV combination test
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Bird flu has begun to spread in mammals
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
-
USDA-ARS scientists announded developing new tests, new ways to track COVID In wild and domestic animals
On Feb. 7, 2023, the U.S. Department of Agricultureﾒs Research Service announced that it was implementing a $300…
-
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://lifesciencehistory.com/wp-content/uploads/2022/08/european_commission_logo-768x768.jpg){kind=logo}
